PGDx Proceeds With Immunotherapy Dx Development Under NCI Grant – GenomeWeb
|
PGDx Proceeds With Immunotherapy Dx Development Under NCI Grant
GenomeWeb PGDx is not alone in its interest in tumor mutation load, or burden, as a strategy to predict immunotherapy response. Foundation Medicine, for example, has also developed an immunotherapy prediction method using it's tissue-based comprehensive targeted … |
